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Abstract 
Back ground: Physiotherapy has a very important role in the maintenance of the integumentary system integrity. There 
is very few evidence in humans. Nevertheless, there are some studies about tissue regeneration using low-level laser 
therapy (LLLT). Aim: To analyze the effectiveness of LILT on scar tissue. Methods: Seventeen volunteers were stratified 
by age of their scars, and then randomly assigned to an experimental group (EG) - n = 9 - and a placebo group 
(PG) - n = 8. Fifteen sessions were conducted to both the groups thrice a week. However, in the PG, the laser device 
was switched off. Scars'  thickness,  length,  width,  macroscopic  aspect,  pain  threshold,  pain  perception,  and  
itching  were  measured. Results: After 5 weeks, there were no statistically significant differences in any variable between 
both the groups. However, analyzing independently each group, EG showed a significant improvement in macroscopic 
aspect (p = 0. 003) using ILLT. Taking into account the scars' age, LILT showed a tendency to decrease older scars' 
thickness in EG. Conclusion: The intervention with LLLT appears to have a positive effect on the macroscopic scars' 
appearance, and on old scars' thickness, in the studied sample. However, it cannot be said for sure that LLLT has 
influence on scar tissue. 
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Introduction 
 
Physiotherapy has a very important role in the maintenance of the i n t e g u m e n t a r y  system i n t e g r i t y , 
intending to improve or restore not only the skin's appearance but also its function (1, 2). There is very few 
evidence in    humans.  Nevertheless, there   are some studies about tissue regeneration using low level laser 
therapy (LLLT) (3-13). 
The wound-healing process   can   be r o u g h l y  divided into three stages: inflammatory, proliferative, 
and r e m o d e l i n g  phases. The inflammatory phase is dominated by hemostasis and acute inflammatory 
response that l a s t s  abou t  24-48 h (14).  The proliferative  phase  is  responsible for  the  formation of  a new  
functional barrier, and  it  lasts  up  to  4  weeks (14-16).  ln the  final  stage   of  wound healing, the remodeling  
phase, there   are  scar   tissue   formation and  maturation of the  wound that  can  be  extended from  6 months 
to 2 years  (14,17). 
The result o f  the normal wound-healing process is the restoration of the architecture and function of 
damaged tissues with the formation of a thin scar and minimal fibrosis, but there are factors that can influence 
this process ( 16). The known factors  that influence   the   normal wound healing are   divided   into general and   
local   (18). The healing   process a l s o  depends on the scar’s anatomical location and its orientation (along   
Langer's lines), skin p h o t o  type, and incision t y p e  (19, 20). 
The application of  LLLT, as  a therapeutic technology, has  grown  significantly in  recent years, 
leading to  developments in  dermatological condition's treatment, which  is being  used  as a promising method 
to  improve the  skin  scars  aesthetically and functionally (2). 
Low-intensity laser r ad i a t i o n  is characterized b y  its ability to induce a non-thermic process ( bio 
stimulation), and it  is monochromatic, coherent, and polarized. This can b e  t r a n s m i t t e d , reflected, 
refracted, and absorbed. The differences between the various   types   of  laser   beams  produced  are  deter- 
mined using  wave lengths, power,  irradiance, energy density, pulse  duration, pulse  repetition rate,  area, and  
beam  mode  (21). 
LLLT is quite helpful in modulating different biological activities, such a s  trophic-regenerative (22-
24), anti-inflammatory (24), a n d  a n a l g e s i c  e f f e c t s  (25). ln  a specific form, changes can be observed  in 
parameters such as adenosine triphosphate (ATP) viability, cytokine expression  (interleukin  6 - IL-6),  cell 
proliferation   (alkaline   phosphatase  enzyme  activity), and   deoxyribonucleic  acid  (DNA)   damage,   directly after 
LLLT. ATP production and cell membrane perturbation could lead to permeability changes and second messenger 
activity resulting in functional changes. The  effect of laser irradiation  on lL-6  is important because a direct 
association  between IL-6, migration and  proliferation   may  accelerate  the  inflammatory phase and reduce  the 
time for complete  wound  healing  (26,27).  The  results  of LLLT  on DNA  damage (as oxidized bases and repair 
in prokaryotic and eukaryotic  cells) may be influenced  by fluencies, frequencies, and wavelength of laser along 
with tissue conditions  and  genetic characteristics  of cells before treatment beginning  (26,28). 
The e n e r g y  must be absorbed   by the tissues in order   to h a v e  effect. The   depth   of penetration 
is greater with the application o f  a perpendicular laser probe, due to reduced r e f l e c t i o n  and scattering, but 
it is always influenced b y  its wavelength. The r a n g e  between 800 and 900 nm can penetrate beyond the 
epidermis, ata very superficial level (about 2-4 mm). However, it can influence the deeper tissues with the cascade 
reaction (29). LLLT's use in animals and humans almost exclusively involves red and near infrared light (600-
1100nm) (24). 
Considering that the scars have a functional a n d  emotional impact on people, they should not be 
considered as an afterthought, but as a change that must be a d d r e s s e d .   ln   this  sense,  LLLT   physiotherapy 
should  be applied, since  there  were observed  effects and results in wound  healing (3,4,6-10,13). The purpose 
of this study was to analyze the effectiveness of LLLT o n  scar tissue, evaluating its effects in thick- ness, length, 
width, macroscopic aspect (color, pig- mentation, elasticity, and height), pain threshold, and pain perception and 
itching, in relation to the scar's age. 
 
Materials and methods 
 
The  target  population of this experimental and  longitudinal   study  was  all  the  students  of  an  
Allied Health  School  in  Oporto, Portugal   (ESTSP), who were invited to participate in the study by e-mail. 
Thirty-five s t u d e n t s  agreed to  be part of the study. As inclusion criteria, the students had to be between 18 
and 25 years, with scars older than three  weeks prior to presentation (30). Laser  contraindications, 
corticosteroids or  anti-coagulants intake, overlapping scars, and performing another   scar's  intervention  
(18,31,32),  and  a  total score  of O  on  the Vancouver  Scar  Scale  (VSS),  or without any thickness confirmed 
by echography were defined as exclusion criteria. 
Considering the previous criteria, 18 individuals were excluded. The final sample consisted  of 17 
participants  who were stratified into four groups,  taking into  account  the  age of their  scars:  group  1 - < 
6 months, group  2 - 6-12 months, group  3 - 12-24 months, and  group  4 - > 24  months.  Participants 
were randomized from each age scar group.  At the end, the experimental group (EG) had 9 participants and 
the placebo group (PG) had 8 participants. Both the g r o u p s    had s e s s i o n s  o f  LLLT   thrice   a we e k  
(Figure 1). Both the groups were prepared s imi l ar ly  for laser application.  Nevertheless, in PG, the device was 
used in safe mode with a security key (it does not allow any radiation). Moreover, as all participants had security 
glasses, seeing the red light coming from the laser device was impossible for them.  
 
Instruments 
 
A social demographic questionnaire was handed to all individuals who volunteered to participate in the study for 
selection and characterization o f  the sample. 
A pilot study took place before the study to analyze instruments' intra-ratter reliability (ICC 3.1), standard 
error of measurement (SEM), and minimal detectable change (MDC) ( 33). ICC was classified according to the 
Fleiss's criteria (1986) (34). Measures were taken with 72 h of interval.  
 
 
Figure 1 - Sample's Diagram
Scar's thickness was measured using TOSHIBA® Viano echo graph with a 7.5-MHz p r o b e  designed 
by a radiology expert. An excellent intra-observer reliability with an ICC (3.1) of 0.99, an SEM of 0.007 mm, and 
an MDC of 0.018 mm (33-36) wa s  observed. 
Scars’ length and  width were measured using a caliper, and intra-ratter reliability found was an ICC 
(3, 1) of 1.0 (34). 
The  Vancouver Scar  Scale  was used  to  evaluate scars' pigmentation, color, elasticity and height, with 
a total score between O and 13, lower scores representing a better macroscopic aspect (37,38).This scale was adapted  
and  validated  to  the Portuguese  population with a content  and  construct  validity of Cronbach's a= O.73. VSS 
showed excellent intra-ratter reliabilities with an ICC (3.1) of 1.0 for the height and color, 0.93 for elasticity, 
O.91 for pigmentation, and O.98 for the total score. Total score also presented an SEM of 0.33 and an MDC of 
0.92 (33, 34). 
Pain perception was assessed using a digital pressure algometer WAGNER® FPI, expressed in kilo- 
grams-force   (kgf), placed p e r p e n d i c u l a r l y    on e a c h  edge of the scar. According to Fernández-de-las-
Pefías and  colleagues  (2006),  a pressure  of 2.5  kgf maintained  for 5 s is enough  to measure  pain perception 
using a visual analogue scale (VAS) (39).This method showed an intra-ratter reliability ICC  (3.1) of0.97, an SEM  
of 0.09, and an MDC of 0.24  (33,34). 
Pain   threshold   was m e a s u r e d    using t h e  s a m e  digital pressure  algometer  placed perpendicularly 
on each edge of the scar and expressed in kgf, beginning in zero kfg and increasing the pressure until a participant   
presented   a  stop  signal  (39),  showing  an intra-ratter reliability ICC  (3.1)  of 0.94, an SEM  of 0.08  kgf, and 
an MDC of 0.21  kgf (33, 34). Itching was measured   using VAS, showing an ICC o f  1.0 (34, 40). 
For LLLT application, an IDEA HP® terza series laser device with a probe of 808 nm was used. 
 
Procedures 
 
A pilot study took place to understand questionnaire and protocol feasibility. 
Inclusion c r i t e r i a  were confirmed u s i n g  echography taken by radiology expert, followed by the 
random distribution of individuals in the EG and PG. 
The s t u d y  h a d  t wo  moments   of evaluation:  an initial one (M1) and a final one (M2) after five 
weeks. The averages of three measurements of each variable (scar's thickness, length, width, pain threshold, pain 
perception, and itching and VSS) were used. 
LLLT was administered to the volunteers according to security guidelines  for low-level lasers (32). 
A diode laser light infrared 8 08  nm with continuous emission o f  500 mW was used.  It was per- formed 
throughout  the scar, with a punctual application with a distance of 1 mm between e a c h  point ( 4 s per 
point). The  applied  energy  density was  4  J/cm 2'   and   the  irradiation  was  1  W/cm2 • The  probe  had  an  
angle  of 90°  and  a distance  of about  1 cm from  the skin surface  (4,21,24,32). The treatment began the 
day-after M 1 , and it was per- formed   thrice a  week (on Mondays, Wednesdays, and Fridays) o v e r  5 weeks 
(4) 
 
Ethics 
 
This study was approved b y  the Ethics Committee  of the ESTSP. Participants, after informed about 
the aims and procedures of the study and after agreeing with them, expressed their consent by signing the 
Declaration of Helsinki.  Ali of them w e r e  able to  refuse or discontinue the study at any time. The 
confidentiality of the data was maintained, and the opportunity to placebo subjects to carry out the intervention 
was given after the study’s end. 
 
 
Statistical analyses 
 
For the statistical analysis of variables in this study, the software PASW Statistics 18 for Windows 7® 
with a significance level of 0.05 (41) was used. 
The sample characterization was performed using descriptive statistics. It was decided to use only non-
- parametric statistics due to a reduced number of participants. For the inter-group comparisons, the Mann-
Whitney test for r a t i o n a l  v a r i a b l e s  a n d  t h e  chi-square test for nominal variables were used. For intra-
group comparisons, the Wilcoxon test for rational variables and the marginal homogeneity test for nominal 
variables were used (41). 
 
 
 
Results 
 
The EG consisted of seven females and two males, and the PG consisted of six females and two males. There 
were no significant differences in the anthropometric measures in both the groups (Table I). 
 
 
Table 1 - Sample's anthropometric characteristics 
 
 
 
 
ln the seventeen participants, whose skin scars that were analyzed in this study, approximately  58.8%  of the  
scars  were  located  in  the  trunk  and  41.2%  in extremities. Regarding the age of scars analyzed, it was found 
that 17.6% were less than six months old, and the same percentage were between 12 and 24 months old. 
Approximately, 29.4% and 35.6% of the target population o f  this study had scars between 6 and 12 months and 
older than 24 months, respectively. There were no significant differences in the localization and in the age of 
scares between EG and PG. 
 
 
lnter-group analysis 
 
After 5 weeks of ILLT application, there were no statistically significant differences in the studied variables 
between the two groups. 
 
Intra-group a n a l y s i s  - Thickness 
 
When comparing EG and PG, MI and M2 thickness decreased s i g n i f i c a n t l y  i n  both t h e  groups, 
r e s p e c t i v e l y    Z = - 2.666    (p = 0.002)    and    Z = - 2.313 (p = 0.012). 
Taking in account MDC thickness, participants in both the groups improved clinically (decreased 
thickness).  Nevertheless, a greater scar’s thickness improvement in EG’s older scars was observed after 5 weeks 
of LLLT (Figure 2) 
 
lntra-group analysis -Vancouver Scar Scale (VSS) 
 
The EG's total VSS score improved after 5 weeks (verified  by   a   decreased   score)   (Z =- 2.673   to p = 
0.003).Therefore, analyzing VSS individual items, only the color and the elasticity were significantly better after 
5 weeks, respectively, as follows: MH  = 18.000 (p = 0.004)   and   MH = 17.000    (p = 0.016).   When analyzing 
MDC VSS items by group, 55.6% o f  the 
  
 
Figure 2 - Median difference in scars’ thickness after 5 weeks of LLLT 
 Intervention.  EG:   experimental   group;   PG:   placebo group.  
 
 
Figure 3 - Positive clinical results of the intervention (MDC), in 
the  total  score  and  in  the  four  items  from  the Vancouver  Scar 
Scale. EG: experimental group; PG: placebo group; H: height; E: 
elasticity; C: color; P: pigmentation
 participants from the EG had clinically relevant improvements in pigmentation, while PG maintained all the 
values (Figure  3). 
 
lntra-group a n a l y s i s  - Pain threshold 
 
After 5  weeks of ILLT, both  the  groups  showed  a significant decrease  in  the  pain  threshold:  for  EG, 
Z=-2.666    (p=0.002), and   for   PG,   Z=-2.380 (p = 0.008). According to MDC pain threshold values, it was 
found that most of the participants in EG and PG had relevant clinical improvements (Figure 4). 
 
lntra-group analysis - Length, width, itching, and  pain perception 
 
Even though  after 5 weeks, there were no significant improvements  in length, width, pain perception, and 
itching  in  EG,  it  is  important  to  refer  that  MDC showed 22.2% clinical improvement  for scars' length 
and 44% for scars' width. It was found that most individuals in both the groups had a clinical improvement in 
pain perception (Figure 4). 
 
 
 
Figure 4 - Positive clinical results of the intervention (MDC), in 
 scars'  length,  width, pain  threshold, pain perception and  itching. 
 EG: experimental group; PG: placebo group.
 
 
  
 Discussion 
 
This study analyzed the effect of LLLT 5-week treat- mem on scars' thickness, macroscopic aspect, 
length, width, itching, pain threshold, and pain perception. ln  fact,  it  cannot  be  said  for  sure  that  LLLT  
has influence  in  all the  studied  variables  as there  were no significant differences between  experimental and 
placebo groups,  mainly due  to the reduced  sample. 
Nevertheless, when observing the groups independently, EG had a significant decrease in the VSS total 
score, after 5 weeks of LLLT, revealing an improvement in the macroscopic appearance of the scars as it was 
found by Gaida and colleagues (2004), in 19 patients with burn scars. These authors used laser therapy with 
similar power, energy density, and duration (4). 
According t o  Huang a n d  colleagues (2009), an  energy  density  between  3  and  5 J/cm2   has  a  best 
positive results in wound healing in vivo (24), supporting  the  use of 4 J/cm 2  in the  present  investigation. 
Energy density appears to be the only treatment parameter   with p r e d i c t a b l e    dose dependent treatment 
effect according to Woodruff and colleagues (2004). These a u t h o r s  h a v e  no doubt t h a t  LLLT is an effective 
modality for treating wounds.  Nevertheless, they also found that the result may be dependent on wave length, 
pulse duration, irradiance, pulse repetition r a t e , treatment time, treatment repetition rate, or a combination 
of all these factors (23). 
Despite   the  Jack of evidence  on  using VSS  by item, the researcher chose to use them independently 
in  order  to  observe  differences  in  specific  aspects. Scar’s elasticity and color (as VSS items) improved 
significantly in EG, with an improvement in MCD pigmentation. Height item VSS results suggested a ceiling 
effect. Brusselaers  and  colleagues  (201O), in a systematic  review of different  scars'  scales, show some 
advantages in using scales, as they are the advantages in the clinical setting, given their low-cost and expenditure 
of time, they are easy to include  in the  clients'  files. The s a m e  authors  p o i n t e d  t h e  importance of their 
validity, reliability and practical application (38). However, the same authors in another study questioned scales 
as they are subjective to evaluate scars, depending on who applies them (42). This aspect wa s  partially 
controlled a s  evaluations we r e  done by the same researcher. 
Scars' thickness was measured  using an echography as ultrasound high frequency  assesses not  only 
the distance  to the surface  of the scar skin, but also in-depth    fibrosis   (42).   There    was   a   significant 
decrease i n  scars’ t h i c k n e s s  ( conjunctive t i s s u e ) in  both the groups.  In fact, the reduced t h i c k n e s s  can 
be explained by a decrease in myofibroblasts' density and an extracellular matrix alteration (43). These changes  
may be due  to natural  wound-healing process  until  24  months,  as  most  of the  scars  of this study  are  in  
the  remodeling  phase  (17).  However, EG   thickness   improvement  on   scars   older   than 24 months, despite 
the Jack of statistical significance, can  be  seen  as  a  possible  favorable  effect  of laser action  on  old scars. 
These  results  are in agreement with Lucas and colleagues (2000), who found that scientifically  LLLT   had   
poor   positive   effects  in human  studies  but  acceptable  clinical  results  (22). The problem of sorting out 
optimum treatment  characteristics for LLLT may be difficult as there are a large number   of variables ( 22, 23).  
Results concerning old scars' thickness improvements u s i n g  LLLT   are n o t  s u p p o r t e d  by  any e v i d e n c e    
being relevant to explore it in future investigations. 
Pain    threshold    measured    by    an    algometer decreased in both the groups. Therefore, it cannot be 
forgotten t h a t  t h e  relationship  b e t w e e n  p a r t i c i p a n t  and researcher can influence pain threshold 
improvement.  ln  fact,  personal   relations  during   5  weeks, thrice  a week, can lead to participant's sense of 
well- being, which leads to a release of opioids by limbic system closing the gate control  and  preventing  pain 
to ascend  to the cortex, where it is recognized  (44). 
Pain perception only had clinical results, where improvements were observed i n  most  s u b j e c t s , i n  
both the groups. These results suggest that digital pressure algometry may be more objective quantifying the 
pain in scars than VAS. 
Laser application did not change scars' length and width in the intervention group when compared with 
those in the control group. However, Hopkins and colleagues (2004) in a randomized controlled  trial, in the 
first two phases of wound healing, found significant improvements   in t h e    scars   when   comparing   the 
groups, but only in superficial scars (abrasions) (3). 
The l i m i t a t i o n s  o f  this s tud y w e r e  the J a c k  of researcher impartiality as well as the limited 
sample. 
For future studies, it is suggested the comparison of the effects of laser with those of other forms of 
assistance: ultrasound, massage therapy, or pressure therapy. It is also suggested that the effects of laser therapy 
should be studied in scars older than 24 months. 
 
 
 
 Conclusion 
 
The intervention with LLLT appears to have a positive effect on the macroscopic appearance on old scars, and 
on old scars thickness, in the studied sample. However, it cannot be said for sure that LLLT has influence on 
scar tissue. 
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